Lv1
40 积分 2026-02-03 加入
Circulating biomarkers in patients with systemic sclerosis–associated interstitial lung disease in the SENSCIS trial
5天前
已完结
Safety and efficacy of blinatumomab in the treatment of refractory systemic sclerosis: a case series
3个月前
已完结
Heterogeneous responses of IM19 anti-CD19 CAR T-cell therapy in refractory systemic lupus erythematosus: an open-label pilot study and a mini-review
6个月前
已关闭
The U.S. Food and Drug Administration’s Perspective on Chimeric Antigen Receptor T-Cell Therapies for Autoimmune and Rheumatic Conditions
6个月前
已完结